Lilly, Novo showcase new obesity drug data; Fasenra falls short in COPD

Lilly claimed success in a head-to-head trial of oral GLP-1 drugs. Elsewhere, Novo planned a new weight loss trial and an AI-focused startup raised its second ‘megaround.’

Mixed reactions trail govt directive on free prepaid electricity meters – EnviroNews

February 1, 2026

Stranded at midnight: How recurrent gridlocks on Lokoja-Abuja highway are putting lives at risk – EnviroNews

February 1, 2026

Source link

Lilly, Novo showcase new obesity drug data; Fasenra falls short in COPD

Mixed reactions trail govt directive on free prepaid electricity meters – EnviroNews

Stranded at midnight: How recurrent gridlocks on Lokoja-Abuja highway are putting lives at risk – EnviroNews

Inside Trumpworld’s Reality Distortion Field

“Africa Needs More Trade, Not Aid”: ATRN10 Sets Bold Agenda for the Future of Tax Research

“Africa Needs More Trade, Not Aid”: ATRN10 Sets Bold Agenda for the Future of Tax Research

Leave a Reply Cancel reply

RECOMMENDED NEWS

Sabotage tool takes on AI image scrapers

UK Gov bank to consider buying into floating wind ports

Nvidia to send 18,000 AI chips to Saudi Arabia

Lagos set to become first in West Africa to eliminate malaria – EnviroNews

POPULAR NEWS

Ghana to build three oil refineries, five petrochemical plants in energy sector overhaul

The world’s top 10 most valuable car brands in 2025

Top 10 African countries with the highest GDP per capita in 2025

Global ranking of Top 5 smartphone brands in Q3, 2024

When Will SHIB Reach $1? Here’s What ChatGPT Says

Lilly, Novo showcase new obesity drug data; Fasenra falls short in COPD

Related posts

Inside Trumpworld’s Reality Distortion Field

“Africa Needs More Trade, Not Aid”: ATRN10 Sets Bold Agenda for the Future of Tax Research

Leave a Reply Cancel reply

RECOMMENDED NEWS

POPULAR NEWS